EN
Patient-first cell therapy innovation
 
Scientific Publication
  • 03.232022
    2018
    Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat Commun. 9(1):5361. (*: Corresponding authors, PMCID: PMC6299138)Jia Q., Wu W., Wang Y., Alexander P.B., Sun C., Gong Z., Cheng J., Sun H., Guan Y.,
  • 03.232022
    Dr. Pin Wang’s Publication
    Dr. Wang has published more than 80 papers on Nature Biotechnology, Cell Stem Cell, PNAS, Nature Communication, ACS Nano, and Molecular Therapy, etc. He has also filed more than 10 patents as lead inventor or co-inventor. Below are some selected papers and patents with significant impacts in the scientific field.
  • 03.232022
    Dr. Qi-Jing Li’s Publication
    Dr. Li has published more than 100 papers on Cell, Cancer Cell, Nature, Nature Immunology, Immunity, EMBO, and Nature Communication, etc. His publications have been cited for more than 9000 times. Below are some selected papers with significant impacts in the scientific field.
12
More

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Product and Cinical trial
News and Media
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer